After adjusting for ALBI grade, AFP group, hepatitis C, insurance status, and treatment received, there was a statistical difference in hazard of death at three years (aHR: 1.9; 95% CI: 1.2, 3.1; p = 0.009) (Table 2), favoring the screened cohort. Here, AFP is linked to hepatitis C virus infection.